Figure 1From: Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer StudyRBM3 expression in primary melanomas and metastases. Examples of malignant melanomas with (A) negative, (B) weak, (C) intermediate and (D) strong immunohistochemical RBM3 staining. RBM3 expression was strong in the majority of (E) primary tumours compared to (F) metastases.Back to article page